X4 Pharmaceuticals Files 8-K on Security Holder Vote
Ticker: XFOR · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1501697
| Field | Detail |
|---|---|
| Company | X4 Pharmaceuticals, Inc (XFOR) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
TL;DR
X4 Pharma had a shareholder vote on April 17th, details in new 8-K.
AI Summary
X4 Pharmaceuticals, Inc. filed an 8-K on April 18, 2025, reporting on a matter submitted to a vote of its security holders on April 17, 2025. The company, formerly known as Arsanis, Inc., is incorporated in Delaware and headquartered in Boston, Massachusetts.
Why It Matters
This filing indicates a formal process where X4 Pharmaceuticals sought approval from its shareholders on a specific matter, which could have implications for the company's governance or strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain information about significant financial changes, legal issues, or operational disruptions.
Key Numbers
- 001-38295 — SEC File Number (Identifies the company's filing history with the SEC.)
- 27-3181608 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- X4 Pharmaceuticals, Inc. (company) — Registrant
- Arsanis, Inc. (company) — Former company name
- April 17, 2025 (date) — Date of earliest event reported
- April 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Boston, Massachusetts (location) — Principal executive offices
FAQ
What specific matter was submitted to a vote of X4 Pharmaceuticals' security holders on April 17, 2025?
The filing does not specify the exact matter voted upon, only that a submission of matters to a vote of security holders occurred on April 17, 2025.
When was the 8-K report filed with the SEC?
The 8-K report was filed on April 18, 2025.
What is X4 Pharmaceuticals' principal executive office address?
The principal executive offices are located at 61 North Beacon Street, 4th Floor, Boston, Massachusetts 02134.
What was X4 Pharmaceuticals' former company name?
The company's former name was Arsanis, Inc.
In which state is X4 Pharmaceuticals incorporated?
X4 Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding X4 Pharmaceuticals, Inc (XFOR).